2.33

2.51% -0.06

After Hours: 2.37 0.04 +1.72%

VolitionRX Ltd (VNRX)

Overview News Price History Option Chain Discussions Forecast

VolitionRX Ltd stock is traded at $2.33, with a volume of 350.50K. It is down -2.51% in the last 24 hours and down -32.07% over the past month. VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.

Previous Close:

$2.39

Open:

$2.41

24h Volume:

350.50K

Relative Volume:

0.64

Market Cap:

$18.46M

Revenue:

$1.73M

Net Income/Loss:

$-23.50M

P/E Ratio:

-0.5334

EPS:

-4.3682

Net Cash Flow:

$-19.37M

1W Performance:

-16.19%

1M Performance:

-32.07%

6M Performance:

-72.98%

1Y Performance:

-76.70%

1-Day Range:

$2.17

$2.4299

1-Week Range:

$2.17

$2.894

52-Week Range:

$2.17

$18.80

VolitionRX Ltd Stock (VNRX) Company Profile

Name

VolitionRX Ltd

Sector

Healthcare (1106)

Industry

Diagnostics & Research (52)

Phone

646 650 1351

Address

No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX

Employee

Twitter

@VolitionRx

Next Earnings Date

2026-05-21

Latest SEC Filings

VNRX's Discussions on Twitter

Compare VNRX vs TMO, DHR, IDXX, WAT, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VNRX VolitionRX Ltd	2.33	18.94M	1.73M	-23.50M	-19.37M	-4.3682
TMO Thermo Fisher Scientific Inc	466.76	171.91B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	174.63	123.18B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	562.97	44.73B	4.30B	1.06B	1.04B	13.08
WAT Waters Corp	342.75	29.63B	3.17B	642.63M	516.49M	10.77
A Agilent Technologies Inc	117.53	31.70B	7.07B	1.29B	993.00M	4.5355

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-08-25	Initiated	H.C. Wainwright	Buy
Feb-01-23	Downgrade	The Benchmark Company	Buy → Hold
Feb-17-22	Resumed	Cantor Fitzgerald	Overweight
Mar-10-21	Initiated	Cantor Fitzgerald	Overweight
May-16-18	Initiated	Maxim Group	Buy
May-14-18	Reiterated	The Benchmark Company	Buy
Sep-07-16	Reiterated	Rodman & Renshaw	Buy
Feb-01-16	Initiated	Rodman & Renshaw	Buy

View All

VolitionRX Ltd Stock (VNRX) Latest News

May 01, 2026

VolitionRx Limited 2025 Annual Report: Executive Compensation, Director Ownership, and Corporate Governance Insights - Minichart

May 01, 2026

VNRX Stock Price, Quote & Chart | VOLITIONRX LTD (NYSEARCA:VNRX) - ChartMill

May 01, 2026

VolitionRX Limited (VNRX) Investment Case | Q4 2025: Earnings UnderperformEV/EBITDA - Newser

May 01, 2026

Apr 30, 2026

CEO pay, board changes and reverse split at VolitionRx (NYSE: VNRX) - Stock Titan

Apr 30, 2026

Apr 29, 2026

VolitionRx (VNRX) Achieves Breakthrough in Sepsis Detection with New Test - GuruFocus

Apr 29, 2026

Sepsis finger-prick test works in hospital study, opening home-use path - Stock Titan

Apr 29, 2026

Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing - Sahm

Apr 29, 2026

Apr 28, 2026

VolitionRx Limited Announces Amendment to Certificate of Incorporation in April 2026 8-K Filing - Minichart

Apr 28, 2026

VolitionRx receives NYSE American compliance plan approval By Investing.com - Investing.com Australia

Apr 24, 2026

Apr 23, 2026

VolitionRx receives NYSE American compliance plan approval - Investing.com

Apr 23, 2026

VolitionRx Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Apr 23, 2026

VolitionRx (NYSE: VNRX) wins NYSE American time to fix listing - Stock Titan

Apr 23, 2026

VolitionRx shares stay on NYSE as exchange accepts compliance plan - Stock Titan

Apr 23, 2026

Apr 21, 2026

D Boral Capital downgrades VolitionRx (VNRX) - MSN

Apr 21, 2026

Apr 20, 2026

VolitionRx launches online shop for recombinant nucleosomes By Investing.com - Investing.com Australia

Apr 20, 2026

VNRX Downgraded by D. Boral Capital -- Rating Changed to Hold - GuruFocus

Apr 20, 2026

VolitionRx Ltd stock (US92852X1037): Does its blood-testing tech unlock real diagnostic upside? - AD HOC NEWS

Apr 20, 2026

D. Boral Capital downgrades VolitionRX stock rating on reverse split By Investing.com - Investing.com South Africa

Apr 20, 2026

D. Boral Capital Downgrades VolitionRX(VNRX.US) to Hold Rating - Moomoo

Apr 20, 2026

After building for 10 years, Volition puts nucleosomes up for sale online - Stock Titan

Apr 20, 2026

Apr 18, 2026

VolitionRx Limited Files Form 8-K With SEC Detailing Company Information and Compliance Data - Minichart

Apr 18, 2026

VolitionRx Ltd stock (US92852X1037): Is its blood-testing breakthrough strong enough to unlock inves - AD HOC NEWS

Apr 18, 2026

VolitionRx Sets One-for-Twenty Reverse Stock Split - The Globe and Mail

Apr 18, 2026

Apr 17, 2026

VolitionRx (VNRX) to execute 1-for-20 reverse stock split on April 28, 2026 - Stock Titan

Apr 17, 2026

Volition approves 1-for-20 reverse stock split effective April 28, 2026 - TradingView

Apr 17, 2026

Apr 14, 2026

VolitionRx Ltd stock (US92852X1037): Why does its blood-testing innovation matter more now for U.S. - AD HOC NEWS

Apr 14, 2026

Apr 06, 2026

H.C. Wainwright cuts VolitionRX stock price target to $1 on share count - Investing.com Australia

Apr 06, 2026

Apr 04, 2026

VolitionRx Earnings Call: Breakthroughs Amid Funding Strain - TipRanks

Apr 04, 2026

VolitionRx Limited (VNRX) stock price, news, quote and history - Yahoo Finance UK

Apr 04, 2026

VNRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 04, 2026

Apr 03, 2026

VolitionRX (VNRX) FY2025 Earnings: Q4 EPS and Revenue Not Disclo - GuruFocus

Apr 03, 2026

VolitionRX Is Maintained at Buy by HC Wainwright & Co. - Moomoo

Apr 03, 2026

VolitionRx Limited (AMEX:VNRX) Q4 2025 Earnings Call Transcript - Insider Monkey

Apr 03, 2026

VolitionRX Q4 Earnings Call Highlights - Defense World

Apr 03, 2026

Apr 02, 2026